Humira Safe and Effective for up to Six Years in Crohn’s Disease Patients, Study Shows

Humira Safe and Effective for up to Six Years in Crohn’s Disease Patients, Study Shows
Humira (adalimumab) is safe and effective for Crohn's disease (CD) patients for up to six years when used in routine clinical practice, a study suggests. The study, "Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn’s Disease: Results of the PYRAMID Registry," was published in the journal Inflammatory Bowel Diseases. Humira is a biological therapy manufactured by AbbVie, a
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *